.png)
Most product launches do not stall because a team suddenly discovers that the product does not work.
They stall later.
The formula may be final. The engineering design may be frozen. Pilot work may be complete. Manufacturing may be preparing for transfer. The project plan may show green.
Yet the product still cannot move forward because a specification has not been reconciled, a supplier record is incomplete, a manufacturing instruction reflects an earlier version, a quality team cannot locate the evidence behind a claim, or a regional product variation has not been connected clearly to the approved master record.
This is the “almost approved” stage.
It is the point at which a product is close enough to launch that commercial expectations are already forming, but not complete enough, in evidence terms, to be released with confidence.
Development complete is not the same as launch ready
R&D teams need milestones. “Formulation locked,” “design frozen,” “pilot complete” and “ready for transfer” are all meaningful markers of progress. But commercialisation requires a different kind of completion.
A launch-ready product is not simply one whose technical work is mostly finished. It is one for which the organisation can show that the correct product definition, specifications, process instructions, supplier information, test results, quality approvals, regulatory requirements, packaging details and market-specific conditions all refer to the same current version. That is harder than it sounds.
Different functions often hold different pieces of the product story:
- R&D holds the latest formula, design or performance data.
- Quality holds test results, deviations, CAPAs and release-related evidence.
- Regulatory holds ingredient, material, documentation or market-access assessments.
- Procurement holds supplier and material-qualification information.
- Manufacturing holds process instructions, line requirements and scale-up evidence.
- Packaging holds artwork, component specifications and compatibility information.
- Product and commercial teams hold claims, customer requirements and launch commitments.
Every function may be doing its work well. But if those records are not connected, no one can easily confirm that they describe the same product version.
Final-mile launch blockers are usually ordinary
The most disruptive commercialisation delays are often small, familiar issues.
A supplier change was assessed in R&D, but the manufacturing record has not been updated. A specification was revised after a method change, but the product release criteria still point to an earlier version. A retailer-specific variation is technically complete, but the labelling or packaging evidence is incomplete. A stability result exists, but it cannot be tied confidently to the formula version now being approved.
None of these problems is inherently dramatic, but they create friction across teams:
- Meetings are held to establish what is still missing.
- People search email threads, shared drives and spreadsheets for evidence.
- Functions circulate parallel product lists to reconcile versions.
- Leaders receive status updates that describe activities, not readiness.
- Launch dates become conditional on reconstruction work rather than product work.
The problem is rarely that people do not care about the launch, but that the product does not have one accessible, controlled operational identity.
A commercial product has multiple definitions
A product is represented in different ways throughout its lifecycle.
It may have a formula or bill of materials, supplier and material records, an approved specification, manufacturing instructions, test methods, test results, packaging components, claims, regulatory assessments, quality approvals and market or customer variants.
These are not separate descriptions that happen to share a product name. They are parts of the same release decision. If they are managed in separate systems or documents without clear relationships, teams can reach the final stage of a project unable to answer a basic question:
Which version of the product are we actually approving?
This becomes especially difficult when changes occur late in development. A raw material is replaced due to supply risk. A specification is tightened after testing. A label claim changes. A customer requests a variant. A manufacturing trial produces a needed process adjustment. A new regional requirement affects permitted ingredients or documentation.
Each change can have downstream impact. The organisation needs to see that impact across the product record, not discover it through a series of meetings near the launch deadline.
Readiness is an evidence question
A percentage-complete project plan can be useful. It is not enough to establish whether a product is ready. A better question is: does the organisation have current, connected evidence for the version it intends to commercialise? The exact requirements vary by industry. But a launch-ready record commonly includes:
- The approved product, formulation or design version.
- Applicable material, ingredient, component and supplier information.
- Current product and packaging specifications.
- Manufacturing instructions and relevant operating parameters.
- Required test methods, results and acceptance criteria.
- Stability, performance, qualification or validation evidence.
- Quality approvals, deviations and open corrective actions.
- Regulatory, safety, labelling or technical-documentation requirements.
- Market-, customer-, site- or channel-specific requirements.
- A clear view of unresolved risks, exceptions and pending decisions.
The point is not to create a longer checklist, but to ensure that the evidence is connected to the correct product version and remains accessible to the people responsible for approval.
Why status reporting misses the real issue
Traditional programme reporting focuses on whether activities are complete.
Testing: complete.
Regulatory review: complete.
Pilot run: complete.
Supplier approval: complete.
Packaging: complete.
That can create a reassuring picture even while the product record remains fragmented.
The final launch meeting then becomes a reconstruction exercise. Teams are not merely reviewing progress. They are trying to prove that a result belongs to the current formula, an approval still applies after a change, a manufacturing instruction matches the tested process, or a regional variant has the evidence required for release.
That work is slow because the problem is relational. The organisation may possess every necessary document and result. It may still struggle to commercialise the product because it cannot demonstrate how those records fit together.
Build commercialisation readiness into development
The most reliable way to avoid the final-mile scramble is to create the product record as development happens.
When R&D updates a formula, the change should be visible to the teams responsible for specifications, supplier qualification, quality evidence and market release. When a method changes, teams should know which tests, trends or acceptance criteria may be affected. When a supplier material changes, the impact should be traceable across formulas, products, production sites and markets.
This does not mean forcing every team into the same workflow. It means connecting the records that contribute to the same product decision.
A connected record makes it easier to identify what is missing earlier. It allows teams to see whether a product change triggered a new qualification need, whether a regional variation still has an open approval or whether a claim lacks the evidence required for release. It turns commercialisation from a last-minute scavenger hunt into a controlled decision process.
The question leaders should ask
Instead of asking only, “Is the project on track?”, leaders should ask:
Can we show, in one place, what version of this product is being approved and the evidence that makes it ready?
If the answer requires multiple spreadsheets, several systems, a long email thread and the presence of the right people in a meeting, the product may be closer to launch than it is to approval.
The final stage of product development is not simply about completing tasks.
It is about ensuring the organisation can trust the product record it is about to commercialise.
Uncountable connects R&D, quality, regulatory, supplier and manufacturing evidence in one product-development environment—so teams can identify launch blockers earlier and bring products to approval with confidence. Let's talk today.
.png)
.png)
.png)
